Article

Hypoxic preconditioned hUC-MSCs enhance its therapeutic efficacy in Lipopolysaccharide…

Research square · 2023 · Yujuan Wang, author Rong Gao, author Bingdi Yan, author Han Li, author Junling Yang, author

Key facts

Title Hypoxic preconditioned hUC-MSCs enhance its therapeutic efficacy in Lipopolysaccharide induced ALI via the TLR4/MyD88 and phosphorylation of PI3K/Akt mediated by TREM-1
First author Yujuan Wang, author Rong Gao, author Bingdi Yan, author Han Li, author Junling Yang, author
Journal Research square
Published Jan 20, 2023
DOI 10.21203/rs.3.rs-1639913/v1
Devices mentioned K973350, K990827
Product codes mentioned CEK, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature